Category: Health

  • Jehovah’s Witnesses to use their own stored blood in medical care — Governing Body clarifies

    Jehovah’s Witnesses to use their own stored blood in medical care — Governing Body clarifies

    INTERNATIONAL (NPA) — March 21, 2026 — On Thursday, April 2, 2026, after sundown, Jehovah’s Witnesses worldwide will gather to commemorate the Memorial of Jesus’ death. This announcement was part of the Governing Body Update #2, 2026, released in a 16-minute video on jw.org. viewed by Newpost Africa on Friday.

    In the update, a member of the Governing Body of Jehovah’s Witnesses, Brother Gerrit Lösch, provided an important clarification regarding the use of a patient’s own blood in medical procedures.

    He explained that Christians obey God by following His command to abstain from blood. While Jehovah’s Witnesses are not under the Mosaic Law, the biblical directive to avoid blood remains binding. However, Lösch noted that the Bible does not specifically address the use of one’s own blood in medical or surgical care.

    As a result, each Witness must personally decide how their own blood may be handled in medical therapy or surgery. This includes routine procedures such as blood tests, as well as more complex treatments involving the temporary removal and reinfusion of blood, such as dialysis or the use of heart-lung machines.

    Brother Lösch stated:  “After much prayer and consideration of the Scriptures, the Governing Body has decided to clarify our position on the use of a patient’s own blood in medical and surgical care. Each patient must decide for himself how his own blood will be used. This includes whether to allow his blood to be removed, stored, and then given back to him.”

    He emphasised that while some Witnesses may choose to permit storage and reinfusion of their own blood, others may object. The decision is a matter of personal conscience.

    Importantly, this clarification does not alter the Witnesses’ long-standing refusal to accept transfusions of donor blood. Instead, it provides members with the freedom to decide whether to use their own stored blood for medical procedures.

  • WHO donates Sh10 million health kits to Kenya

    WHO donates Sh10 million health kits to Kenya

    AFRICA (Agency Report/Michael Omondi) — March 21, 2026 —The Ministry of Health has received emergency health kits from the World Health Organization (WHO) valued at approximately Sh 10 million to support Kenya’s response to the ongoing March–April–May (MAM) long rains and flooding, affecting several parts of the country.

    The donation was received on behalf of the Cabinet Secretary (CS) for Health, Aden Duale, by Secretary Administration Mr Adan Halakhe from the Ministry and WHO Acting Representative to Kenya Dr Neema Rusibamayila Kimambo during a handover ceremony held at Afya House, Nairobi.

    Secretary, Administration in the Ministry of Health, Mr Adan Halakhe, delivers the remarks of the Cabinet Secretary for Health, Aden Duale, when he received the emergency health kits from the World Health Organisation to support Kenya’s response to the ongoing March–April–May (MAM) long rains and flooding affecting several parts of the country at Afya House, Nairobi, on 18th March, 2026. Looking on is the World Health Organization (WHO) Acting Representative to Kenya, Dr Neema Rusibamayila Kimambo.

    In his remarks, CS Duale expressed appreciation to WHO for the timely support, noting that the contribution will strengthen Kenya’s capacity to respond to public health risks associated with flooding.

    The CS reported that the emergency kits, which contain essential medicines, medical supplies and life-saving equipment, will support frontline health workers in providing critical care, managing disease outbreaks and maintaining essential health services in affected areas.

    Further, he noted that the ongoing long rains have led to flooding in several counties, resulting in displacement of families, disruption of services and increased risk of disease outbreaks.

    Equally, the CS reaffirmed the Government’s commitment to protecting the health and wellbeing of Kenyans, noting that the Ministry, working closely with county governments and partners, has activated emergency preparedness and response mechanisms to ensure communities at risk receive timely health services.

    “These efforts include strengthening disease surveillance, supporting rapid response teams, ensuring the availability of essential medicines and enhancing public awareness on preventive measures during the rainy season,” Duale highlighted.

    He urged members of the public to remain vigilant by maintaining proper hygiene, using safe water, sleeping under treated mosquito nets and seeking early medical care when experiencing symptoms of illness.

    Speaking during the handover, WHO Kenya Acting Representative, Dr Neema Rusibamayila Kimambo, expressed condolences to families affected by the floods and reaffirmed WHO’s commitment to supporting Kenya’s response efforts.

    She observed that flooding across several counties has disrupted access to safe water, sanitation and essential health services, increasing the risk of diseases such as cholera and malaria.

    Meanwhile, the emergency supplies handed over include cholera case management kits, rapid diagnostic and investigation kits, water treatment supplies and trauma kits expected to support health services for approximately 5,000 people in the most affected areas.

    The event was attended by Director of Public Health, Dr Stephen Muleshe; WHO officials; and senior Ministry of Health officials.

  • UN decries slow progress in reducing child mortality as 5m die annually

    UN decries slow progress in reducing child mortality as 5m die annually

    INTERNATIONAL (Agency Report) — March 21, 2026 — The United Nations has decried the slow progress in reducing child mortality as 4.9 million children still die annually before their fifth birthday.

    Some UN agencies under the aegis of the UN Inter-agency Group for Child Mortality Estimation (UN IGME) stated this in a statement issued on Wednesday, according to a new report.

    The new UN report on child mortality fully assesses leading causes of under five deaths for first time.

    It states that an estimated 4.9 million children died before their fifth birthday in 2024, including 2.3 million newborns, according to new estimates released on Wednesday.

    The report also notes that most of these deaths are preventable with proven, low-cost interventions and access to quality healthcare.

    According to the report, titled: “Level and Trends in Child Mortality,”  under-five deaths globally have fallen by more than half since 2000.

    However, it says since 2015, the pace of reduction in child mortality has slowed by more than 60 per cent.

    “This year’s report provides the clearest and most detailed picture yet of how many children, adolescents, and youth are dying, where they are dying, and – for the first time – fully integrates estimates on the causes of death.

    “For the first time, the report estimates deaths directly caused by Severe Acute Malnutrition (SAM), finding that more than 100,000 children aged 1-59 months – or 5 per cent – died from it in 2024.

    “The toll is far greater when indirect effects are considered, as malnutrition weakens children’s immunity and increases their risk of dying from common childhood diseases,” the report says.

    The statement quoted UNICEF Executive Director, Catherine Russell as saying: “No child should die from diseases that we know how to prevent.

    “However, we see worrying signs that progress in child survival is slowing – and at a time where we’re seeing further global budget cuts.

    “History has shown what is possible when the world commits to protecting its children. With sustained investment and political will, we can continue to build on those achievements for future generations.”

    Commenting on the report, WHO Director-General, Tedros Ghebreyesus, said: “The world has made remarkable progress in saving children’s lives, but many still die from preventable causes.

    “Children living amid conflict and crisis are nearly three times more likely to die before their fifth birthday.

    “We must protect essential health and nutrition services and reach the most vulnerable families so every child has the chance not only to survive, but to thrive.”

    Also reacting to the report, World Bank Group Director, Health, Monique Vledder, said: “These findings are a collective call to speed up implementation of the proven, scalable solutions we know are within reach.

    “The World Bank Group health target of reaching 1.5 billion people is our concrete commitment to accelerating access to quality primary health services for more children and families.”

    The report further stated that mortality data also frequently fail to capture SAM as an underlying cause of death, suggesting the burden is likely substantially underestimated.

    Some of the countries with the highest numbers of direct deaths include Pakistan, Somalia, and Sudan.

    “Newborn deaths account for nearly half of all under-five deaths, reflecting slower progress in preventing deaths around the time of birth.

    “Leading causes among newborns were complications from preterm birth (36 per cent) and complications during labour and delivery (21 per cent).

    “Infections, including neonatal sepsis and congenital anomalies, were also important causes,” the report further says.

    Beyond the first month, the report states that infectious diseases such as malaria, diarrhoea, and pneumonia are major killers.

    It notes that malaria remains the single largest killer in this age group (17 per cent) – with most deaths occurring in endemic areas of sub-Saharan Africa.

    After steep declines between 2000 and 2015, progress towards reducing malaria mortality slowed in recent years.

    It further reveals that deaths remain concentrated in a handful of endemic countries – such as Chad, Democratic Republic of the Congo, Niger, and Nigeria.Nigerian government news

    The report explains that these are where conflict, climate shocks, invasive mosquitos, drug resistance, and other biological threats continue to affect access to prevention and treatment.

    “Child deaths remain heavily concentrated in a small number of regions. In 2024, sub-Saharan Africa accounted for 58 per cent of all under-five deaths.

    “In the region, the leading infectious diseases were responsible for 54 per cent of all under-five deaths.

    “In Europe and North America this proportion drops to 9 per cent and in Australia and New Zealand, it drops further to 6 per cent. These stark disparities reflect unequal access to proven, life-saving interventions,” it says.

    According to the report, fragile and conflict-affected countries continue to bear a disproportionate share of the burden.

    Children born in these settings are nearly three times more likely to die before their fifth birthday than those elsewhere.

    The report also finds that an estimated 2.1 million children, adolescents and youth aged 5–24 died in 2024.

    Infectious diseases and injuries remain leading causes among younger children, while risks shift in adolescence, with self-harm being the leading cause of death among girls aged 15–19, and road traffic injuries among boys. (NAN).

  • NAFDAC warns of counterfeit cancer drug PHESGO 600mg in Nigeria

    NAFDAC warns of counterfeit cancer drug PHESGO 600mg in Nigeria

    LAGOS, NIGERIA (NPA) — March 17, 2026 — The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert on confirmed counterfeit PHESGO 600mg with batch numbers B2346B16 and C3809C5.

    In Public Alert No. 014/2026, the agency noted that Roche, the Marketing Authorisation Holder of the cancer drug, received complaints from Lagos University Teaching Hospital (LUTH-NSIA) of suspected counterfeit Phesgo® 600mg. Batch C3809C5 was found to contain approximately 20mL instead of the expected 10mL. Both products were brought in by patients for administration.

    NAFDAC stated: “Only pictures of the complaint samples were sent to Roche. Although a complete investigation was not possible, the pictures were scrutinised and compared to genuine retained samples.”

    The investigation revealed major discrepancies confirming falsification, including:

    • Non-existent batch number in Roche’s database
    • Incorrect text and variable data
    • GTIN mismatch
    • Missing tamper-evidence label
    • Significant packaging differences

    Batch B2346B16 has been reported in four confirmed counterfeit complaints across Turkey, Nigeria, and the Philippines, all featuring the same fake batch number and false information.

    Phesgo 600mg, used to treat breast cancer, works by killing cancer cells and preventing further growth. Genuine Phesgo 600mg/600mg is manufactured by F. Hoffman La Roche Limited, Wurmisweg, CH-4303, Kaiseraugst, Switzerland.

  • WHO Nigeria lists contraceptive options for the sexually active amid low use

    WHO Nigeria lists contraceptive options for the sexually active amid low use

    ABUJA, NIGERIA — (NPA) March 16, 2026 — The World Health Organisation (WHO) Nigeria has outlined several contraceptive methods available to prevent pregnancy for both men and women.  

    In a statement posted on X, the global health body categorised contraceptives into hormonal methods, non-hormonal options such as condoms and copper IUDs, permanent surgical procedures like vasectomies or female sterilisation, and emergency contraception after intercourse. 

    WHO noted that effectiveness varies, and not all methods suit everyone, urging individuals to consult health workers for guidance.  

    Despite widespread awareness, contraceptive use in Nigeria remains low. Academic Journals report that only 12–18% of women of reproductive age use modern contraceptives, contributing to high rates of unintended pregnancies, unsafe abortions, and sexually transmitted infections. Fertility and maternal mortality rates remain among the highest globally. 

    However, challenges persist. Cultural and religious resistance, spousal opposition, myths about side effects, limited access in rural areas, and inadequate youth-friendly services all hinder uptake. These barriers continue to drive high fertility rates and poor reproductive health outcomes, underscoring the urgent need for stronger education, policy support, and community engagement.

  • NEMA warns Nigerians on fire risks amid heatwave, encourages residents to monitor weather forecasts

    NEMA warns Nigerians on fire risks amid heatwave, encourages residents to monitor weather forecasts

    ABUJA, NIGERIA — (NPA) MARCH 14 — The National Emergency Management Agency (NEMA) has cautioned Nigerians about heightened risks of fire disasters and heat-related health challenges following the recent surge in daily temperatures across parts of the country.

    In a statement signed by Manzo Ezekiel on March 14, quoting Director-General Mrs Zubaida Umar, the agency warned of persistent heat conditions during this period and urged citizens to exercise caution in handling materials and appliances that could easily ignite under extreme heat.

    Umar advised households, businesses, and public institutions to ensure the safe use of electrical appliances, gas cylinders, and other combustible items, stressing that excessive heat increases their vulnerability to ignition. She further emphasised proper storage of flammable substances, avoidance of bush burning, and maintenance of electrical connections to reduce fire risks.

    Beyond fire safety, NEMA urged citizens to guard against heat-related health issues by staying hydrated, limiting direct sun exposure, and paying special attention to vulnerable groups such as children, the elderly, and those with underlying health conditions. The agency also encouraged residents to monitor weather forecasts and safety advisories from NiMet and other emergency bodies, and to promptly report any fire outbreak or emergency.

    Mrs Umar reaffirmed NEMA’s commitment to continuous public awareness and proactive disaster risk reduction, in line with the Federal Government’s efforts to safeguard lives, property, and the environment.

  • 3.1 million Kenyans living with chronic kidney disease, says Health Ministry

    3.1 million Kenyans living with chronic kidney disease, says Health Ministry

    NAIROBI, KENYA (Agency Report/By Michael Omondi) — March 13, 2026 — Approximately 3.1 million Kenyans are living with Chronic Kidney Disease (CKD), a growing public health concern driven by rising cases of hypertension and diabetes, the Ministry of Health has said.

    Speaking during World Kidney Day at Kenyatta National Hospital, Health Cabinet Secretary Aden Duale noted that non-communicable diseases (NCDs) account for 43 percent of all deaths in Kenya, underscoring the need for prevention, early diagnosis, and management. He said the government is prioritising routine screening for blood pressure and glucose at community and primary healthcare levels.

    Access to specialised kidney care is expanding under the Social Health Authority (SHA), which has processed over Sh104 billion in claims, supporting dialysis, nephrectomy, and transplants. Duale added: “The Ministry is strengthening partnerships with accredited providers to widen access to transplant services, with patients now able to receive kidney transplantation at Aga Khan University Hospital Nairobi under SHA-approved packages.”

    To improve governance and oversight, the Ministry has set up an independent review committee and is developing a National Transplant Registry. Investments are also being made in training and infrastructure through the East Africa Centre of Excellence in Urology and Nephrology, alongside new renal units across counties.

    The forthcoming Kenya National Guidelines for Kidney Diseases 2026 will standardise care nationwide, supported by integrated health data systems under the Digital Superhighway initiative. Duale urged Kenyans to adopt healthy lifestyles, including regular check-ups, physical activity, hydration, and reduced salt intake.

    Present at the event were Director-General for Health Dr. Patrick Amoth and Kenyatta National Hospital CEO Dr. Richard Lesiyampe. (Kenya News Agency).

  • Ministry of Health reaffirms commitment to maternal and newborn care

    Ministry of Health reaffirms commitment to maternal and newborn care

    ABUJA, NIGERIA (NPA) — March 13, 2026 — The Federal Ministry of Health and Social Welfare has reaffirmed its commitment to strengthening maternal and newborn health services nationwide following the successful delivery of quadruplets at the Federal Medical Centre (FMC), Abeokuta, Ogun State.

    In a statement signed by Ado Bako, Assistant Director of Information & Public Relations, the ministry said Mrs. Mufiat Olateju was referred to the hospital while in labor, where medical teams promptly managed the high-risk delivery and stabilized both mother and babies. Acting on the directive of Minister of State for Health, Dr. Iziaq Adekunle Salako, FMC Abeokuta ensured comprehensive care and monitoring for the family.

    The ministry commended the professionalism of the medical team, noting that multiple births require specialized care. It emphasized the importance of early and consistent antenatal visits to detect complications, improve outcomes, and ensure safer deliveries. Pregnant women were urged to register early at recognized health facilities and maintain regular contact with qualified professionals.

    The ministry also highlighted the role of postpartum counselling and voluntary family planning in promoting family wellbeing. It reiterated its commitment to reducing preventable maternal and infant deaths through stronger health systems, skilled personnel, and expanded access to quality care.

  • NEMA trains naval personnel and students on disaster management in Port Harcourt

    NEMA trains naval personnel and students on disaster management in Port Harcourt

    PORT HARCOURT, NIGERIA (NPA) — March 13, 2026 — The National Emergency Management Agency (NEMA) has conducted disaster management training for naval personnel and students of the Nigerian Navy Secondary School in Brokiri Town, Port Harcourt, Rivers State.

    The exercise, held on March 11, was supervised by NEMA’s Head of Operations, Eric Ebodaghe, and aimed at strengthening preparedness and response capacity among officers and students of the naval institution. Training sessions covered flood management, evacuation procedures, fire prevention, and practical evacuation drills.

    Facilitators, including Mr. Anyanwu Fortunatus and Mr. Felix Akakara, led interactive sessions and coordinated a hands-on evacuation drill involving all participants.

    In a statement, Ebodaghe urged participants to take the training seriously, noting that the skills acquired would be vital in responding effectively to emergencies. 

    Responding on behalf of the institution, Lt. Cdr. A.M. Koko expressed appreciation to NEMA for the initiative and conveyed gratitude to Director-General Zubaida Umar for supporting the program.

  • NAFDAC raises alarm over counterfeit Avastin 400mg in Nigeria

    NAFDAC raises alarm over counterfeit Avastin 400mg in Nigeria

    LAGOS, NIGERIA (NPA) — March 12, 2026 — The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert regarding confirmed counterfeit versions of Avastin 400mg circulating in Nigeria.

    Avastin (bevacizumab), an anti-angiogenic therapy that starves tumours of blood supply, is commonly prescribed for the treatment of recurrent glioblastoma in adults.

    In Public Alert No. 012/2026, NAFDAC reported that Roche, the Marketing Authorisation Holder (MAH), received a complaint from an oncologist at a local hospital about suspicious Avastin vials (400 mg/16 ml) with batch numbers K1830T71 and H0375B01.

    According to Roche, the complaint sample was compared with a genuine retained sample in the EFA (English, French, and Arabic) packaging presentation. The GTIN (Global Trade Item Number) on the folding box matched the EFA presentation, but several discrepancies were identified:

    1. The batch numbers do not exist in Roche’s database, making lot tracing impossible.
    2. The packaging artwork contained incorrect text and spelling errors.
    3. Variable data was inaccurate and inconsistently placed.
    4. Tamper-evidence labels did not match genuine Roche materials.
    5. The serial number on the complaint sample did not correspond to any authentic Roche serial number.

    NAFDAC emphasized that these findings confirm the presence of counterfeit packaging. The agency reiterated that Avastin (bevacizumab) is indicated for the treatment of recurrent glioblastoma in adults and warned healthcare providers to remain vigilant.

    The alert concluded with a public advisory to healthcare professionals and consumers to report any suspicion of substandard or falsified medicines or medical devices to the nearest NAFDAC office, call 0800-162-3322, or email sf.alert@nafdac.gov.ng.